| Literature DB >> 26318793 |
Telma Luciana Furtado Gouveia1, Paula Viviane Vieira de Sousa1, Sandro Soares de Almeida2, Mariana Bocca Nejm1, Joíse Marques Vieira de Brito1, Roberta Monterazzo Cysneiros3, Marlon Vilela de Brito4, Bruno Ramos Salu4, Maria Luiza Vilela Oliva4, Fúlvio Alexandre Scorza1, Maria da Graça Naffah-Mazzacoratti5.
Abstract
During the epileptogenic process, several events may occur, such as an important activation of the immune system in the central nervous system. The response to seizure activity results in an inflammation in the brain as well as in the periphery. Moreover, CRP and cytokines may be able to interact with numerous ligands in response to cardiac injury caused by sympathetic stimulation in ictal and postictal states. Based on this, we measured the serum levels of C-reactive protein (CRP) and cytokines during acute, silent, and chronic phases of rats submitted to the pilocarpine model of epilepsy. We have also analyzed the effect of a chronic treatment of these rats with omega-3 fatty acid in CRP and cytokine levels, during an epileptic focus generation. C-reactive protein and cytokines such as IL-1β, IL-6, and TNF-α presented high concentration in the blood of rats, even well after the occurrence of SE. We found reduced levels of CRP and all proinflammatory cytokines in the blood of animals with chronic seizures, treated with omega-3, when compared with those treated with vehicle solution. Taken together, our results strongly suggest that the omega-3 is an effective treatment to prevent SUDEP occurrence due to its capability to act as an anti-inflammatory compound, reducing the systemic inflammatory parameters altered by seizures.Entities:
Keywords: C-reactive protein; Cytokines; Epileptogenesis; Omega-3 fatty acid; Pilocarpine; Temporal lobe epilepsy
Mesh:
Substances:
Year: 2015 PMID: 26318793 DOI: 10.1016/j.yebeh.2015.07.021
Source DB: PubMed Journal: Epilepsy Behav ISSN: 1525-5050 Impact factor: 2.937